Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
出版年份 2019 全文链接
标题
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-10-17
DOI
10.1038/s41598-019-51287-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- NK cell therapy for hematologic malignancies
- (2018) Rohtesh S. Mehta et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia
- (2018) Wen-Ting Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
- (2018) Folashade Otegbeye et al. PLoS One
- Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma
- (2018) Jodi Chiu et al. Frontiers in Immunology
- IL-2 mediates NK cell proliferation but not hyperactivity
- (2017) Richa Sharma et al. IMMUNOLOGIC RESEARCH
- Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival
- (2017) Matteo Donadon et al. JOURNAL OF GASTROINTESTINAL SURGERY
- The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma
- (2017) Kristina von Heyking et al. Molecular Oncology
- Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
- (2017) Markus Granzin et al. Frontiers in Immunology
- The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
- (2017) Sarah Parisi et al. Frontiers in Immunology
- A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma
- (2017) Juliane Wagner et al. Frontiers in Immunology
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Expanded and armed natural killer cells for cancer treatment
- (2016) Noriko Shimasaki et al. CYTOTHERAPY
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
- (2016) Claudia Cantoni et al. Journal of Immunology Research
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
- (2016) Markus Granzin et al. OncoImmunology
- Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds
- (2015) K. Lagrue et al. BLOOD
- Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
- (2015) Carin I. M. Dahlberg et al. Frontiers in Immunology
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Infusions of Allogeneic Natural Killer Cells as Cancer Therapy
- (2014) W. Leung CLINICAL CANCER RESEARCH
- The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
- (2014) Antoine Marçais et al. NATURE IMMUNOLOGY
- Clinical utility of natural killer cells in cancer therapy and transplantation
- (2014) David A. Knorr et al. SEMINARS IN IMMUNOLOGY
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Metabolic Pathways in Immune Cell Activation and Quiescence
- (2013) Erika L. Pearce et al. IMMUNITY
- Irradiated and Activated Autologous PBMCs Induce Expansion of Highly Cytotoxic Human NK Cells In Vitro
- (2013) Yong-Oon Ahn et al. JOURNAL OF IMMUNOTHERAPY
- MYC, Metabolism, Cell Growth, and Tumorigenesis
- (2013) C. V. Dang Cold Spring Harbor Perspectives in Medicine
- Clinical Relevance of Natural Killer Cells Following Hematopoietic Stem Cell Transplantation
- (2013) Jeanne M Palmer et al. Journal of Cancer
- Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
- (2013) Ulrike Koehl et al. Frontiers in Oncology
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1
- (2012) A. Glasner et al. JOURNAL OF IMMUNOLOGY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Natural killer cell distribution and trafficking in human tissues
- (2012) Paolo Carrega et al. Frontiers in Immunology
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
- (2011) Ruoning Wang et al. IMMUNITY
- CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
- (2010) S. Lopez-Verges et al. BLOOD
- Activating and inhibitory receptors of natural killer cells
- (2010) Hollie J Pegram et al. IMMUNOLOGY AND CELL BIOLOGY
- Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
- (2010) Caroline J Voskens et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
- (2010) Silke Paust et al. NATURE IMMUNOLOGY
- NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
- (2010) Vivien Béziat et al. PLoS One
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
- (2009) Maria Berg et al. CYTOTHERAPY
- Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
- (2007) Rosanne Spolski et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More